- Home
- SNTI vs LODE Comparison
SNTI vs LODE Comparison
Compare SNTI & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- LODE
- Stock Information
- Founded
- SNTI 2016
- LODE 2008
- Country
- SNTI United States
- LODE United States
- Employees
- SNTI N/A
- LODE N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- LODE Major Chemicals
- Sector
- SNTI Health Care
- LODE Industrials
- Exchange
- SNTI Nasdaq
- LODE Nasdaq
- Market Cap
- SNTI 50.3M
- LODE 53.0M
- IPO Year
- SNTI N/A
- LODE N/A
- Fundamental
- Price
- SNTI $1.70
- LODE $3.28
- Analyst Decision
- SNTI Strong Buy
- LODE Buy
- Analyst Count
- SNTI 2
- LODE 1
- Target Price
- SNTI $8.50
- LODE $26.00
- AVG Volume (30 Days)
- SNTI 511.1K
- LODE 400.5K
- Earning Date
- SNTI 08-12-2025
- LODE 08-11-2025
- Dividend Yield
- SNTI N/A
- LODE N/A
- EPS Growth
- SNTI N/A
- LODE N/A
- EPS
- SNTI N/A
- LODE N/A
- Revenue
- SNTI N/A
- LODE $3,376,027.00
- Revenue This Year
- SNTI N/A
- LODE $24.69
- Revenue Next Year
- SNTI $150.00
- LODE N/A
- P/E Ratio
- SNTI N/A
- LODE N/A
- Revenue Growth
- SNTI N/A
- LODE 102.20
- 52 Week Low
- SNTI $1.52
- LODE $1.26
- 52 Week High
- SNTI $16.94
- LODE $10.10
- Technical
- Relative Strength Index (RSI)
- SNTI 29.96
- LODE 41.24
- Support Level
- SNTI $1.86
- LODE $3.32
- Resistance Level
- SNTI $2.12
- LODE $3.58
- Average True Range (ATR)
- SNTI 0.15
- LODE 0.23
- MACD
- SNTI 0.00
- LODE -0.06
- Stochastic Oscillator
- SNTI 0.00
- LODE 1.47
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.